✨ Medicines Distribution Consents
2 NOVEMBER 2006
NEW ZEALAND GAZETTE, No. 126
3699
Product: Tramal SR 50
Active Ingredient: Tramadol hydrochloride 50mg
Dosage Form: Modified release tablet
New Zealand Sponsor: CSL New Zealand Limited
Manufacturers: Farmaceutici Formenti Italy, Origgio (VA), Italy
Grunenthal GmbH, Stolberg, Germany
Product: Vinorelbine Pierre Fabre
Active Ingredient: Vinorelbine tartrate 27.7mg equivalent to vinorelbine 20mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Pierre Fabre Medicament Australia Pty Limited
Manufacturer: R P Scherer & Co. KG., Eberbach/Baden, Germany
Product: Vinorelbine Pierre Fabre
Active Ingredient: Vinorelbine tartrate 41.55mg equivalent to vinorelbine 30mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Pierre Fabre Medicament Australia Pty Limited
Manufacturer: R P Scherer & Co. KG., Eberbach/Baden, Germany
Product: Vinorelbine Pierre Fabre
Active Ingredient: Vinorelbine tartrate 55.4mg equivalent to vinorelbine 40mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Pierre Fabre Medicament Australia Pty Limited
Manufacturer: R P Scherer & Co. KG., Eberbach/Baden, Germany
Product: Vinorelbine Pierre Fabre
Active Ingredient: Vinorelbine tartrate 110.8mg equivalent to vinorelbine 80mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Pierre Fabre Medicament Australia Pty Limited
Manufacturer: R P Scherer & Co. KG., Eberbach/Baden, Germany
Product: Winthrop Oxaliplatin
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for infusion
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-L’Alleud, Belgium
Product: Winthrop Oxaliplatin
Active Ingredient: Oxaliplatin 50mg
Dosage Form: Powder for infusion
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-L’Alleud, Belgium
Dated this 26th day of October 2006.
KAREN MITCHELL, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7559
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Velcade
Active Ingredient: Bortezomib 3.5mg
Dosage Form: Powder for injection
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Dated this 26th day of October 2006.
KAREN MITCHELL, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7561
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 126
Gazette.govt.nz —
NZ Gazette 2006, No 126
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare26 October 2006
Medicines, Distribution, Pharmaceuticals, Health, Tramal SR 50, Vinorelbine Pierre Fabre, Winthrop Oxaliplatin
- Karen Mitchell, Acting Deputy Director-General, Public Health
🏥 Consent to the Distribution of a Changed Medicine
🏥 Health & Social Welfare26 October 2006
Medicines, Distribution, Pharmaceuticals, Health, Velcade
- Karen Mitchell, Acting Deputy Director-General, Public Health